NASDAQ · ADGM
Healthcare · Medical - Devices
$0.58
Down-$0.02 (-3.28%)
Updated Sep 12, 2026, 1:46 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 19 trading sessions · Daily adjusted prices
ADGM closed at $0.58 after 19 trading sessions, down 16.21% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $0.59 | $0.6203 | $0.5718 | $0.58 | 100.76K |
| Sep 9, 2026 | $0.595 | $0.6398 | $0.5802 | $0.605 | 69.24K |
| Sep 8, 2026 | $0.579 | $0.6398 | $0.55 | $0.6075 | 180.6K |
| Sep 4, 2026 | $0.534 | $0.5899 | $0.53 | $0.564 | 297.6K |
| Sep 3, 2026 | $0.54 | $0.5478 | $0.525 | $0.5407 | 63.78K |
| Sep 2, 2026 | $0.5249 | $0.5399 | $0.5005 | $0.5299 | 233.16K |
| Sep 1, 2026 | $0.5399 | $0.5399 | $0.5025 | $0.5124 | 91.36K |
| Aug 31, 2026 | $0.5288 | $0.5498 | $0.485 | $0.5284 | 279.8K |
| Aug 28, 2026 | $0.515 | $0.543 | $0.50 | $0.511 | 230.47K |
| Aug 27, 2026 | $0.54 | $0.5499 | $0.515 | $0.5203 | 120.25K |
| Aug 26, 2026 | $0.54 | $0.5647 | $0.5107 | $0.522 | 329.39K |
| Aug 25, 2026 | $0.581 | $0.606 | $0.55 | $0.55 | 570.64K |
| Aug 24, 2026 | $0.6402 | $0.6615 | $0.556 | $0.5901 | 436.64K |
| Aug 21, 2026 | $0.63 | $0.6798 | $0.62 | $0.6491 | 351.11K |
| Aug 20, 2026 | $0.629 | $0.6501 | $0.623 | $0.6341 | 111.15K |
| Aug 19, 2026 | $0.6397 | $0.6684 | $0.63 | $0.632 | 304.09K |
| Aug 18, 2026 | $0.6442 | $0.6522 | $0.625 | $0.646 | 281.23K |
| Aug 17, 2026 | $0.70 | $0.70 | $0.6257 | $0.6515 | 696.51K |
| Aug 14, 2026 | $0.6953 | $0.73 | $0.6671 | $0.6922 | 643.58K |
The latest Smart Investors Daily articles mentioning ADGM.
ADGM research
Company profile and research snapshot.
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 3, 2026 | LUCID CAPITAL MARKETS | Buy | — |
| Apr 14, 2026 | Piper Sandler | Overweight | — |
| Dec 2, 2025 | Lake Street | Buy | — |
No generated briefing is available yet.
Benzinga · Aug 11, 2026
Adagio Medical Holdings (NASDAQ:ADGM) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.31) by 3.23 percent. This is a 14.29 percent increase over losses of $(0.35) per
Benzinga · Aug 4, 2026
Adagio stock jumps after first patient receives next-generation VT ablation system under FDA authorization.
Benzinga · Aug 3, 2026
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the successful
Benzinga · Jun 3, 2026
LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Adagio Medical Holdings (NASDAQ:ADGM) with a Buy rating and announces Price Target of $3.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ADGM.
